Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
ConclusionSecukinumab is the most cost-effective treatment option for patients with moderate-to-severe psoriasis compared with other commonly used biologics from the Chinese healthcare system perspective.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: China Health | Dermatology | Enbrel | Humira | Psoriasis | Remicade | Skin | Stelara | Study